A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan drops Cambodia from visa facilitation programs, extends others
07/17/2026 08:49 PM - Sports
TPBL top pick Adam Hinton ready to cook in Taiwan
07/17/2026 08:22 PM - Society
- Society
Court orders Central Union Oil executive detained in tainted oil case
07/17/2026 07:48 PM - Society
Chang Gung builds Taiwan's first life-course gut microbiome database
07/17/2026 06:30 PM